1. New Editorial Advisory Board Members and a Thank You

   Commentary 10 March 2023 Pages: 77 - 77

2. Two compartmental fractional derivative model with general fractional derivative

   • Vesna Miskovic-Stankovic
   • Marko Janev
   • Teodor M. Atanackovic

   Original Paper 08 December 2022 Pages: 79 - 87

   

3. Convolution-based approach for modeling the paliperidone extended release and Long-Acting Injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of new LAI products

   • Roberto Gomeni
   • Françoise Bressolle-Gomeni

   Original Paper Open access 09 December 2022 Pages: 89 - 96

   

4. Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects

   • Kyung Mi Kim
   • Byung-Moon Choi
   • Gyu-Jeong Noh

   Original Paper 16 December 2022 Pages: 97 - 109

   

5. Generative models for age, race/ethnicity, and disease state dependence of physiological determinants of drug dosing

   • Rahul Nair
   • Deen Dayal Mohan
   • Murali Ramanathan

   Original Paper 24 December 2022 Pages: 111 - 122

   

6. Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling

   • Mutaz M. Jaber
   • Richard C. Brundage

   Original Paper 08 January 2023 Pages: 123 - 132

   

7. Latent variable indirect response modeling of clinical efficacy endpoints with combination therapy: application to guselkumab and golimumab in patients with ulcerative colitis

   • Chuanpu Hu
   • Marion Vetter
   • Daniele Ouellet

   Original Paper 17 January 2023 Pages: 133 - 144

   

8. Correction to: Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials

   • Kumar Kandadi Muralidharan
   • Kenneth G. Kowalski
   • Ivan Nestoro

   Correction 04 March 2023 Pages: 145 - 145